Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,848 total articles
Palantir crushed Q2, sent the stock up 27% and left momentum high but valuation very rich. This trade idea lays out a disciplined long entry after the post-earnings rally, with exact entry, stop and target, plus the fundamental and technical reasoning that justifies a mid-term swing trade.
Rigel is no longer just a clinical-stage story. With an FDA-approved oral PROTAC (VEPPANU) and an established hematology product (Tavalisse), the company sits at an attractive valuation (market cap ~$775M) with near-term commercial catalysts and demonstrated free cash flow. This trade buys a pullback into technical support and positions for revenue…
SCHD (Schwab US Dividend Equity ETF) offers 3%+ yield, a low cost structure and exposure to 100 high-quality dividend payers. With bullish technicals and a recent stretch of outperformance, a mid-term long trade sized to limit downside and capture income plus rally upside is an actionable way to reduce portfolio volatility in a risky market environ…
Miami International (MIAX) looks like a growth exchange still in the early innings of network effects. Rising liquidity, a debt-free balance sheet and expanding product mix support continued upside. I upgrade MIAX to a mid-term long trade with clear entry, stop and target levels.
GEMI's collapse from its IPO highs priced in a lot of bad news. With market cap near $0.5B, an enterprise value under $400M and heavy short interest, the stock is priced for failure. A disciplined long entry at $4.05 with a $3.70 stop and a $6.50 target offers asymmetric upside if the company can stabilize operations, provide clearer guidance on it…
Pinterest is trading well below its 52-week high after a year of advertising bounces and founder liquidity events. The stock offers $1.2B in free cash flow, an enterprise value near $14.9B and a valuation that looks reasonable versus its cash-generation profile. This trade targets a rebound to $30 over a multi-month position while protecting downsi…
Broadcom has faced near-term noise from compute-cycle weakness, but a structural shift toward optical interconnects across cloud, AI, and networking should drive durable revenue leverage. This trade idea upgrades Broadcom to a long stance. Entry $1000.00, target $1300.00, stop $850.00. Time horizon: long term (180 trading days).
SoFi reported a strong Q2 with $1.2B in revenue (up ~43% YoY), massive tangible book growth and improving cross-sell, but the stock dropped after management held adjusted EBITDA and EPS guidance. The fundamentals argue this is a durable fintech franchise; the market’s reaction opens a swing trade with asymmetric upside if cross-sell momentum contin…
NGL Energy Partners has turned its Water Solutions segment into a high-margin growth engine. With $660M adjusted EBITDA in 2026, a completed $950M refinancing, and management guidance of $715-$725M for 2027, the setup favors a re-rate. This trade targets share-price recovery and multiple expansion while respecting balance-sheet risk.
Enel's share price is carving higher on steady fundamentals and constructive technicals. With a market cap of $117.6B, a 2.42% yield and a P/E of 24.4, the stock looks positioned to continue a grid-led re-rating. This trade targets further upside while protecting capital on a defined stop.
Palantir reported $1.9B in Q2 revenue (93% YoY) and raised FY guidance to roughly $8.15B, signaling that enterprise AI adoption is accelerating beyond government work. The stock is richly valued, but momentum, improving fundamentals, and a still-small commercial AI penetration argue for a targeted long trade over the next 180 trading days with a st…
Freshworks is showing durable multi-product sales strength, positive cash flow, and improving profitability while trading at a reasonable multiple for a software company. We like a risk-defined long trade at current levels ($11.50) targeting a re-rating to $16.00 over a 180 trading-day horizon, with a stop at $9.75.
PayPal is trading near $58 with a $60.50 takeover proposal on the table that the board has already deemed inadequate. The company generates $6.6B in free cash flow and trades at roughly 7.6x P/FCF and ~11x P/E. I view $60 as too low; this idea lays out a long trade with entry, stop and targets tied to both a negotiated takeover path and operational…
Cass Information Systems reported strong earnings, healthy cash generation, and continues to return capital to shareholders. With EPS of $2.74, a $0.32 quarterly dividend, modest leverage and an expanding technical trend, I am upgrading my stance and laying out an actionable long trade with clear entry, stop and target.
Subaru (FUJHY) trades near the low end of its 52-week range with a sub-1.0 PB, a 3.5% yield and improving policy/tariff tailwinds. We upgrade to a Buy and lay out a mid-term (45 trading days) trade: entry $7.80, stop $7.10, target $10.50. Risk is real — tariff shifts, EV transition costs and heavy short activity can keep price volatile — but the ri…
Watsco (WSO) faces margin normalization after an outsized 2025 pricing tailwind, but cash flow, a conservative balance sheet, and e-commerce traction make the stock an attractive long-term trade. Enter on weakness with a defined stop and a 180-trading-day time horizon to capture margin recovery, acquisition synergies, and continued dividend compoun…
Nano Labs is a Hangzhou-based fabless semiconductor and AI compute solutions company trading at a $43.9M market cap. Recent strategic moves into AI data-center infrastructure and insider buying create a clear thesis for an asymmetric long trade. The stock is cheap on headline multiples, has a small float, and technicals show stabilizing momentum — …
Stoke Therapeutics looks buyable here on a mid-term swing basis. The setup combines improving clinical readouts, a concentrated short base, and technical momentum around $32.05. Valuation is aggressive but event-driven upside and a high short-interest backdrop make a disciplined long trade attractive for the next 45 trading days.
MPLX is a fee-driven midstream operator that sits close to its 52-week high but still offers a 7%+ yield, strong free cash flow, and a pipeline of expansion projects. This trade targets steady income and capital appreciation over a 180-trading-day horizon with a clear entry, stop and target.
Harmony Gold (HMY) combines deep-level South African assets, an open-pit footprint and a copper exposure that together position it to benefit from a sustained gold rally and rising margin tailwinds. At a market cap near $11.94B and a P/E of ~11.2, the stock still trades below prior cycle highs and offers asymmetric upside versus downside if bullion…
Booking Holdings trades at reasonable multiples vs. its cash generation and profitability. With FY2025 revenue of $26.9B, ~20% net margins and roughly $9B in free cash flow, a modest acceleration in earnings growth would drive the stock to sub-1x PEG territory. I’m initiating a long with a clear entry, stop and target and a mid-term horizon to capt…
Hut 8 has converted itself from a crypto miner into an AI and HPC infrastructure owner-operator, locking multi-year leases that imply tens of billions in contracted revenue. The market is pricing growth into the shares ($96.18 current), and while valuation is rich (market cap ~$11.3B, P/S ~36), the combination of long-duration contracted cash flows…
FMCB reported consecutive record quarters, increased its dividend to $5.35 quarterly and expanded buybacks — signals of durable profitability and capital discipline. The stock trades at $1,391.25 on OTC Link with bullish technical momentum but extremely light liquidity. This trade idea outlines a clear entry, stop and two targets across a 180-tradi…
HF Sinclair (DINO) is an attractive swing long while refined-product tightness persists. The company combines exposure to outsized crack spreads with low leverage, strong free cash flow ($2.24B), and an attractive valuation (P/E ~8.4, EV/EBITDA ~5.7). Enter at current levels, keep a clear stop below the 50-day moving average, and target the 52-week…
Accendra Health (ACH) trades at a sub-$250M market cap with heavy short interest, depressed technicals, and stretched negative sentiment ahead of Q2. Fundamentals are messy - negative EPS and large free cash flow deficits - but valuation metrics (price-to-sales, EV/EBITDA) and a deep float open the door for a mid-term rebound if the quarter shows s…
